CSA Biotechnologies
PrivateCompany Overview
CSA Biotechnologies is a clinical-stage biotechnology company that develops ceragenin-based therapeutics for the treatment of Epidermolysis Bullosa and other conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
cerageninantimicrobial peptidesepidermolysis bullosachronic wound caresynthetic therapeuticssmall-molecule drugswound healingpreclinical developmentdrug discoverybiotechrare disease therapeuticsskin-fragility diseasedrug licensingpharma partneringorphan drug
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CSA Biotechnologies Comparables
Compare CSA Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Phoenicis Therapeutics | 85% | |
| BioMendics | 84% | |
| Aegle Therapeutics Corp | 83% | |
CSA Biotechnologies Funding Rounds
Historical fundraising activity
CSA Biotechnologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CSA Biotechnologies's valuation, stock price, and market status.
Firmographic Details
HeadquartersChandler, Arizona
Employee Range1
Year Founded2012
Last Funding—
See something wrong or outdated?